HEMATOLOGIC DISEASES
Clinical trials for HEMATOLOGIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Frozen testicle tissue may help men become dads after childhood cancer
Disease control Recruiting nowThis study tests whether testicular tissue frozen before puberty can be transplanted back into adult men to restore sperm production. Five men who had fertility-threatening treatments as children will receive their own preserved tissue. The goal is to see if sperm can be found in…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
CRISPR stem cell therapy could end transfusions for sickle cell and thalassemia patients
Disease control Recruiting nowThis study tests a one-time treatment called CTX001, which uses CRISPR gene editing to modify a patient's own stem cells to produce more fetal hemoglobin. The goal is to reduce or eliminate the need for blood transfusions in people with transfusion-dependent beta-thalassemia or s…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cell therapy aims to supercharge immune recovery in young cancer patients
Disease control Recruiting nowThis early-phase study tests whether a special cell therapy called T-allo10 can safely help rebuild the immune system in children and young adults (up to age 45) with blood cancers who have received a stem cell transplant. The treatment is given after the transplant to speed up r…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Engineered immune cells take aim at tough leukemia
Disease control Recruiting nowThis early-stage study tests a new treatment called IL-5 CAR-T cell therapy for people with a rare and hard-to-treat blood cancer called eosinophilic leukemia. The therapy uses a patient's own immune cells, modified to target and attack cancer cells. The main goals are to check s…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Card game aims to ease tough End-of-Life talks for cancer patients
Symptom relief Recruiting nowThis study tests whether a simple card game, the Go Wish Game, can help people with advanced blood cancers or solid tumors discuss their end-of-life priorities with doctors. About 75 patients will use the cards to sort what matters most to them, then complete an advance care plan…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Blood cancer patients may get transfusions at home in hospice trial
Symptom relief Recruiting nowThis study tests a new program that gives blood cancer patients access to blood transfusions at home while they receive hospice care. The goal is to see if this improves their quality of life, mood, and reduces hospital visits near the end of life. The trial will include 700 adul…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 26, 2026 17:39 UTC
-
Bone needle could save lives when veins collapse in blood disease emergencies
Knowledge-focused Recruiting nowThis study looks at using a needle placed into the bone marrow (intraosseous infusion) to give fluids and medicines quickly to critically ill patients with blood diseases. Researchers will enroll 52 adults aged 18-65 to see how often the first attempt works and how safe it is. Th…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Shanxi Bethune Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
High-Altitude stem cell transplant registry launches in tibet
Knowledge-focused Recruiting nowThis study is a registry that tracks patients with blood diseases who receive stem cell transplants at a hospital on the Qinghai-Tibet Plateau. Researchers will collect information on recovery, complications, and costs over time. The goal is to understand how high altitude affect…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Yigeng Cao,MD,PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC